Vapotherm, which provides noninvasive breathing aids to treat respiratory distress, filed on Friday with the SEC to raise up to $58 million in an initial public offering.
The Exeter, NH-based company was founded in 1993 and booked $41 million in revenue for the 12 months ended September 30, 2018. It plans to list on the NYSE under the symbol VAPO. Vapotherm filed confidentially on August 24, 2018. BofA Merrill Lynch and William Blair are the joint bookrunners on the deal. No pricing terms were disclosed.
